BackSpencer Pharmaceutical Overview

Spencer Pharmaceutical Receivables

Track Spencer Pharmaceutical's receivables ($640K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$644379.00
↑ 214693.00% YoYΔ $644079.00 vs prior year quarter

Peer trimmed avg / median

Loading

Spencer Pharmaceutical Receivables History

Loading

Spencer Pharmaceutical vs. peers: Receivables Comparison

Loading

Spencer Pharmaceutical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Spencer Pharmaceutical (SPPH) FAQ

Spencer Pharmaceutical's receivables stands at $640K as of March 2004. That compares with $300 in the prior-year period — up 214693.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Spencer Pharmaceutical reported $640K in receivables versus $300 a year earlier — a 214693.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $300 in the prior-year period — up 214693.0% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Spencer Pharmaceutical's receivables evolved across reporting periods, while the comparison chart places SPPH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.